<DOC>
	<DOCNO>NCT01980498</DOCNO>
	<brief_summary>The primary objective present phase IIIb study ass efficacy FPNS compare Physician Choice-Usual Care ( PC-UC ) reduction swallow predictable BTP head neck cancer patient undergo radiotherapy without chemotherapy .</brief_summary>
	<brief_title>PEctin Rapid Fentanyl Efficacy Clinical Trial For pAin Swallowing Undergoing radioTherapy</brief_title>
	<detailed_description>Population : In patient head neck cancer undergo radiotherapy , regardless day radiotherapy treatment , without chemotherapy take least 60 mg oral morphine daily equianalgesic dose another opioid control background pain ( background pain control defined NRS &lt; 4 ) uncontrolled pain swallowing ( moderate/severe intensity : ≥ 4 NRS 0-10 ) . Study design : Patients sign ICF meet inclusion exclusion criterion randomly assign 1:1 receive one follow predictable BTP swallow treatment : 1 . Fentanyl pectin nasal spray ( FPNS ) 2 . Physician choice-Usual Care ( PC-UC ) Each patient take drug 3 episode day ( main meal : breakfast , lunch dinner ) 15 episode total 6 ( -1 , +2 ) consecutive day . At episode patient record pain baseline ( drug administration ) , 10 , 20 30 minute take FPNS PC-UC . At meal , administer dose FPNS PC-UC adequately effective pain control , patient allow take rescue medication IRMS 30 min FPNS PC-UC administration .</detailed_description>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Fentanyl</mesh_term>
	<mesh_term>Pectin</mesh_term>
	<criteria>Inclusion criterion : 1 . Male female age 18 year 2 . Diagnosis stage IIIIV cancer oral cavity , oropharynx , hypopharynx , larynx , salivary gland 3 . Receiving radiation therapy ( RT ) without concurrent platinum base chemotherapy cetuximab first line treatment postoperative adjuvant treatment 4 . Background pain control least 60 mg oral morphine daily equianalgesic dose another opioid . A `` background pain control '' define NRS &lt; 4 5 . Uncontrolled pain swallowing ( predictable BTP swallowing ) intensity ≥4 11point numeric scale ( 0=no pain ; 10=worst possible pain ) . This pain measure ingestion solid/liquid food ( depend ability swallow less solid food patient moment ) 6 . Patients able receive nasal spray therapy 7 . Willing able sign inform consent form 8 . Females childbearing potential must provide negative pregnancy test male female must use adequate contraception study 9 . Patients PEG jejunostomy , available take mouth meal ( solid liquid ) liquid order compliant protocol . 1 . Patients know metastatic disease 2 . Known hypersensitivity opioids , Fentanyl drug use PCUC , and/or study medication ' formulation ingredient 3 . Patients impaired chemistry laboratory exam , assess routine clinical practice radiotherapy start : a. Hepatic function : . Total bilirubin &gt; 2 time uppernormal limit ( ULN ) ii . Serum transaminase &gt; 5 time ULN b. Renal function : i. Serum creatinine concentration &gt; 2 time ULN 4 . Pregnant breastfeed woman 5 . Patients unlikely comply protocol unable understand nature , scope possible consequence study 6 . Patients plan receive investigational treatment study period 7 . Patients moderate severe respiratory impairment 8 . Patients nasogastric feed tube 9 . Patients take FPNS accord investigator 's judgment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2014</verification_date>
</DOC>